|
Main
|
|
Note: This record shows only the 20 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ClinicalTrials.gov |
|
Last refreshed on:
|
17 October 2012 |
|
Main ID: |
NCT00899873 |
|
Date of registration:
|
09/05/2009 |
|
Primary sponsor: |
|
|
Public title:
|
Biomarkers in Samples From Patients With Chronic Lymphocytic Leukemia Treated on Clinical Trial ECOG-2997
|
|
Scientific title:
|
Proposed Study of CLL Samples |
|
Date of first enrolment:
|
August 2008 |
|
Target sample size:
|
225 |
|
Recruitment status: |
Not yet recruiting |
|
URL:
|
http://clinicaltrials.gov/show/NCT00899873 |
|
Study type:
|
Observational |
|
Study design:
|
N/A
|
|
|
Contacts
|
|
Name:
|
David Kaplan, MD, PhD |
|
Address:
|
|
|
Telephone:
|
|
|
Email:
|
|
|
Affiliation:
|
University Hospitals Seidman Cancer Center |
| | |
|
Key inclusion & exclusion criteria
|
DISEASE CHARACTERISTICS:
- Stored frozen viable cells from patients with chronic lymphocytic leukemia treated on
clinical trial ECOG-2997
PATIENT CHARACTERISTICS:
- Not specified
PRIOR CONCURRENT THERAPY:
- Not specified
Age minimum:
18 Years
Age maximum:
N/A
Gender:
Both
|
|
Health Condition(s) or Problem(s) studied
|
|
Leukemia
|
|
Intervention(s)
|
|
Genetic: cytogenetic analysis
|
|
Other: flow cytometry
|
|
Other: fluorescence activated cell sorting
|
|
Other: immunoenzyme technique
|
|
Other: laboratory biomarker analysis
|
|
Primary Outcome(s)
|
|
Correlation of biomarker analysis with complete response
[Time Frame: No]
|
|
Correlation of biomarker analysis with overall survival
[Time Frame: No]
|
|
Correlation of biomarker analysis with progression-free survival
[Time Frame: No]
|
|
Secondary ID(s)
|
|
CDR0000617494
|
|
ECOG-E2997T1
|
|
Source(s) of Monetary Support
|
|
Please refer to primary and secondary sponsors
|
|